Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-02-11T17:00:51.982Z Has data issue: false hasContentIssue false

The role of Plasmodium knowlesi in the history of malaria research

Published online by Cambridge University Press:  10 November 2016

G. A. BUTCHER
Affiliation:
Retired. Formerly, Faculty of Life Sciences, Imperial College, London, UK
G. H. MITCHELL*
Affiliation:
School of Biological Sciences, University of Essex, Wivenhoe Park, Colchester, Essex CO3 4SQ, UK
*
*Corresponding author: School of Biological Sciences, University of Essex, Wivenhoe Park, Colchester, Essex CO3 4SQ, UK. E-mail: gmitch@essex.ac.uk

Summary

In recent years, a malaria infection of humans in South East Asia, originally diagnosed as a known human-infecting species, Plasmodium malariae, has been identified as a simian parasite, Plasmodium knowlesi. This species had been subject to considerable investigation in monkeys since the 1930s. With the development of continuous culture of the erythrocytic stages of the human malarial parasite, Plasmodium falciparum in 1976, the emphasis in research shifted away from knowlesi. However, its importance as a human pathogen has provoked a renewed interest in P. knowlesi, not least because it too can be maintained in continuous culture and thus provides an experimental model. In fact, this parasite species has a long history in malaria research, and the purpose of this chapter is to outline approximately the first 50 years of this history.

Type
Special Issue Review
Copyright
Copyright © Cambridge University Press 2016 

“A P. knowlesi infection in a human ….would probably be diagnosed as P. malariae” Garnham (Reference Garnham1966)

INTRODUCTION

In his book ‘Man's Mastery over Malaria’, the eminent malariologist Paul Russell quoted a remark by Ronald Ross: ‘an historical introduction is always necessary to give coherence to ideas’. If for no other reason, this seems to justify an account of the history of Plasmodium knowlesi in malaria research (Russell, Reference Russell1955). Despite the estimated annual numbers of 250 million cases and 2·5 million deaths due to malaria in Russell's time, he was optimistic concerning the ultimate victory over this disease. The number of cases has fallen dramatically since 1955, and there is renewed optimism that malaria will eventually be eliminated. However, malaria always seems to have a surprise for us, and, in this case, it is that P. knowlesi, traditionally considered an infection of monkeys, is now known to be endemic in humans in Southeast Asia.

The parasite is widespread, clinically relevant and potentially lethal (Cox-Singh and Singh, Reference Cox-Singh and Singh2008; Cox-Singh et al. Reference Cox-Singh, Davis, Lee, Shamsul, Matusop, Rahman, Conway and Singh2008). This should not have been entirely unexpected, as P. knowlesi was known to infect humans (shown by Knowles and Das Gupta, Reference Knowles and Das Gupta1932) when it was first formally described and systematically named by Sinton and Mulligan (Reference Sinton and Mulligan1932) and subsequently had been widely used to treat patients with neurosyphilis by induced pyrexia (e.g. van Rooyen and Pile, Reference van Rooyen and Pile1935; Ciuca et al. Reference Ciuca, Ballif, Chelaresco, Lavrineko and Zotta1937). Work of this kind in patients (and experiments in volunteers) led to some insights into the variability of infection in man (see ‘Pathology of P. knowlesi infection’ section below). Interestingly, the likelihood that naturally occurring human infections of this parasite would be found was discussed by Garnham in his classic volume on malaria parasites (Garnham, Reference Garnham1966). In fact, the first demonstrably natural zoonotic infection of man in peninsular Malaysia had already come to academic attention, having been acquired by a man working at night in the bush in 1965 (Chin et al. Reference Chin, Contacos, Coatney and Kimball1965). Garnham also correctly predicted that P. knowlesi would be misdiagnosed in a routine laboratory as P. malariae because of the similarity of the gametocytes of the two species, or alternatively as P. falciparum if only ring forms were present. The newly appreciated zoonotic importance of the species has now contributed to renewed interest in the malaria parasites of macaque monkeys and their potential as experimental models.

STRAINS AND SUBSPECIES OF P. KNOWLESI

The importance of human P. knowlesi is beginning to lead to molecular identification and clarification of differences amongst isolates. Whilst formally described and named in 1932 (loc cit), the species had almost certainly been seen but not formally described before this in macaques (perhaps first by Franchini, Reference Franchini1927; cited by Garnham, Reference Garnham1966; Coatney et al. Reference Coatney, Collins, Warren and Contacos1971), and other workers who were not (in the words of the latter) ‘taxonomic addicts’ and left this nomenclatural work to ‘the brave’. Apart from the five early monkey isolations of Sinton and Mulligan from Macaca fascicularis – K1, K2, K3, K4 and C, differentiated by levels of cross-immunity (Mulligan and Sinton, Reference Mulligan and Sinton1933) – numerous other isolations of the type species have been used in the laboratory, notably ‘Nuri’ from Negeri Sembilan in peninsular Malaysia (Edeson and Davey, Reference Edeson and Davey1953), ‘Malaysian’ (Collins et al. Reference Collins, Contacos, Skinner, Chin and Guinn1967) and ‘Phillipines’ (Lambrecht et al. Reference Lambrecht, Dunn and Eyles1961), which were all isolated from monkeys, whist ‘H’ was isolated from the human case mentioned above (Chin et al. Reference Chin, Contacos, Coatney and Kimball1965). ‘Hackeri’ was isolated directly from a vector mosquito, Anopheles hackeri (Wharton and Eyles, Reference Wharton and Eyles1961) in Malaya. No significant differences have been noted in blood stage morphologies or pathology, but in the early years of genetic analysis of parasites a difference was found to exist in the circumsporozoite protein gene repeat sequence between H and Nuri. This involved both the number of repeat sequences and the sequence of amino acids in each repeat (Sharma et al. Reference Sharma, Svec, Mitchell and Godson1985). It may be that such a difference is not taxonomically important (Mun et al. Reference Mun, Ahmed, Wong, Yee and Sitam2015), but full genomic data are not yet apparently available for Nuri.

Historically three sub-species divergent from the type have been recognized, for instance by Garnham (Reference Garnham1966): P.k.edesoni, P.k.sintoni, and P.k.arimai. These were isolated in Malaysia, Java and Taiwan (infecting Macaca cyclopis), respectively. Their distinguishing features were in blood-film morphology and colouration on staining, and in varying propensities to sequester schizonts (Garnham, Reference Garnham1966). Like the type species, all are quotidian; P. knowlesi is the only primate malaria with a 24 h asexual cycle in the blood. P. k.edesoni was found by Coatney et al. (Reference Coatney, Collins, Warren and Contacos1971) to be much less pathogenic in rhesus than the type, but they report the sub-species as lost. They also record that Yokogawa was reported by Hsieh (Reference Hsieh1960) as stating that the Taiwanese parasite, P. k. arimai, would not infect man. It is not clear how these sub-species relate to populations studied more recently, where a number of clinical isolates have seemed to fall into two distinguishable genomic clusters (Ahmed et al. Reference Ahmed, Pinheiro, Divis, Siner, Zainudin, Wong, Lu, Singh-Khaira, Millar, Lynch, Willmann, Singh, Krishna and Cox-Singh2014; Pinheiro et al. Reference Pinheiro, Ahmed, Millar, Sanderson, Otto, Lu, Krishna, Rayner and Cox-Singh2015). Similarly lines derived from isolates used in laboratories have been compared genomically with clinical isolates and with the prototype genome (Pain et al. Reference Pain, Böhme, Berry, Mungall, Finn, Jackson, Mourier, Mistry, Pasini, Aslett, Balasubrammaniam, Borgwardt, Brooks, Carret, Carver, Cherevach, Chillingworth, Clark, Galinski, Hall, Harper, Harris, Hauser, Ivens, Janssen, Keane, Larke, Lapp, Marti and Moule2008) and confirm two current ‘clinical’ genomic clusters together with a group formed by several laboratory isolates (Assefa et al. Reference Assefa, Lim, Preston, Duffy, Nair, Adroub, Kadir, Goldberg, Neafsey, Divis, Clark, Duraisingh, Conway, Pain and Singh2015) Unfortunately it is now essentially certain that the material for the first knowlesi genome did not derive from ‘H’ strain as believed by the authors (Pain et al. Reference Pain, Böhme, Berry, Mungall, Finn, Jackson, Mourier, Mistry, Pasini, Aslett, Balasubrammaniam, Borgwardt, Brooks, Carret, Carver, Cherevach, Chillingworth, Clark, Galinski, Hall, Harper, Harris, Hauser, Ivens, Janssen, Keane, Larke, Lapp, Marti and Moule2008), but, as a result of a misunderstanding several decades ago, came from a distinct Malaysian isolate (Collins et al. Reference Collins, Contacos, Skinner, Chin and Guinn1967) (Collins, 1978, personal communication; Barnwell, 2016, personal communication; Barnwell, MS in preparation). This mislabelling was strongly suspected by Assefa et al. (Reference Assefa, Lim, Preston, Duffy, Nair, Adroub, Kadir, Goldberg, Neafsey, Divis, Clark, Duraisingh, Conway, Pain and Singh2015) from their comparative results. Both H and Malaysian are geographically from peninsular Malaysia. The latter however has had a protracted history of rhesus monkey passage (e.g. Barnwell et al. Reference Barnwell, Howard, Miller, Evered and Whelan1983; Howard et al. Reference Howard, Barnwell and Kao1983), and parasites derived from the same isolation and used by the present authors, but referred to as W strain, had, for instance, ceased to produce observable numbers of gametocytes. As found with cultured P. falciparum, artificial passage may have profound effects; possibly such are reflected in the ‘laboratory cluster’ seen by Assefa et al. (Reference Assefa, Lim, Preston, Duffy, Nair, Adroub, Kadir, Goldberg, Neafsey, Divis, Clark, Duraisingh, Conway, Pain and Singh2015).

HOSTS AND THE P. KNOWLESI-RHESUS MODEL

The definitive (mosquito) hosts of the species were not historically well understood. Anopheles hackeri was clearly one (Wharton and Eyles Reference Wharton and Eyles1961), and Anopheles balabacensis was found to be a vector in early survey work (Cheong et al. Reference Cheong, Warren, Omar and Mahadevan1965) but it has taken molecular methods to establish the importance of A. balabacensis, a far more anthropophilic species than hackeri, as crucial in the bionomics of this malaria as a zoonosis in Sabah (Wong et al. Reference Wong, Chua, Leong, Khaw, Fornace, Wan-Sulaiman, William, Drakeley, Ferguson and Vythilingam2015) as well as having been a reliable laboratory vector in work on experimental transmission (see Coatney et al. Reference Coatney, Collins, Warren and Contacos1971). Numerous other Anopheles spp. are also known to be vectors, of which A. cracens was found biting both man and monkeys in a recent survey in peninsular Malaysia (Jiram et al. Reference Jiram, Vythilingam, NoorAzian, Yusof, Azahari and Fong2012) and Anopheles latens was the principal vector found for P knowlesi in the Kapit District of Sarawak, Malaysian Borneo (Tan et al. Reference Tan, Vythilingam, Matusop, Chan and Singh2008). Vectors have been reviewed recently by Collins (Reference Collins2012).

The most frequent natural intermediate host of P. knowlesi is the kra, crab-eater or long-tailed macaque, M. fascicularis (previously Silenus irus = M. irus) but knowlesi has also been found in M. nemestrina, M. cyclopis and Presbytis melalophus (Garnham, Reference Garnham1966). A very full summary of the definitive and vertebrate hosts capable of supporting the parasite is given by Coatney et al. (Reference Coatney, Collins, Warren and Contacos1971). These authors also review the sporogonic and exoerythrocytic development in great depth. The tissue cycle is some 120–140 h, and sporogony takes 12–15 days.

The crab-eating macaque is found in Northern Thailand, through the Malay peninsula and throughout Indonesia and in the Phillipines (Wheatley, Reference Wheatley1980). Although M. fascicularis may be simultaneously infected with P. coatneyi, P. fragile and Plasmodium cynomolgi, none of these parasites causes their hosts any severe symptoms (Butcher, Reference Butcher1996). In early survey work by several authors across this monkey's range, summarized by Aberle (Reference Aberle1945), some 26% of M. fascicularis were found to carry malaria parasites of various species. In contrast to the kra, the closely related rhesus monkey (Macca mulatta) is extraordinarily sensitive to P. knowlesi and can even be infected with only ten parasitized erythrocytes (Butcher, Reference Butcher1970). The infection continues unabated until almost all red cells are infected and the animal dies with shock and anaemia, usually about a week or so after infection. There are some rhesus, which may be more resistant, since where these two closely related monkey species are sympatric in Northern Thailand there is some interbreeding (Wheatley, Reference Wheatley1980; Butcher, Reference Butcher1996).

PLASMODIUM KNOWLESI IN VITRO: STUDYING THE PARASITE OUTSIDE ITS HOST

From the early years of the 20th century there was interest in maintaining malaria parasites in vitro. This was driven in part by a desire to understand the biochemistry of the organism per se, for instance, distinguishing essential from inessential compounds, but also to remove the parasite from the host immune response and other variables of its physiology. Once cyclical development and multiplication was achieved in vitro, antibody activity and other immune effectors could be titrated.

The importance of being able to study a parasite outside its host could not be over rated. The observation that P. falciparum would develop in human blood, when incubated in tubes to which glucose had been added (Bass and Johns, Reference Bass and Johns1912) suggested long term in vitro culture was feasible. During World War II the US Army began a programme to define the conditions required for maintaining malaria parasites in vitro, with a major focus on P. knowlesi. The culture medium devised by the US Army workers in 1946 was based on an analysis of monkey plasma and became known as the ‘Harvard Medium’ (Anfinsen et al. Reference Anfinsen, Geiman, McKee, Ormsbee and Ball1946; Geiman et al. Reference Anfinsen, Geiman, McKee, Ormsbee and Ball1946; McKee and Geiman, Reference McKee and Geiman1946; Ball et al. Reference Ball, McKee, Anfinsen, Cruz and Geiman1948). In addition, these authors also tested a wide variety of culture vessels, determined the optimum levels of oxygen in the gas phase and measured glucose uptake and lactic acid production. Because of the rapid growth of P. knowlesi (glycolysis is 25 times faster in parasitized red cells compared with uninfected erythrocytes; Bertagna et al. Reference Bertagna, Cohen, Geiman, Haworth, Konigk, Richards and Trigg1972) the medium required considerable buffering capacity to keep the pH between 7·2 and 7·5. Initially this was supplied by N-glycylglycine, later replaced by HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid). Nevertheless, parasite yield was still limited by cell concentration and the frequency or rate at which used medium was removed and fresh medium added: hence the importance attached to the design of culture vessels to achieve optimum growth.

A further factor-limiting parasite replication in vitro was the condition of the normal uninfected red cells taken from an infected monkey but which deteriorated rapidly at 37 °C, as judged by reduced susceptibility to merozoite invasion (Trigg and Shakespeare, Reference Trigg and Shakespeare1976). It was thought this may have been due to the presence of malarial toxins affecting the red cell membranes, as Dunn (Reference Dunn1969) reported alterations in sodium concentrations, and De Zeeuw et al. (Reference De Zeeuw, Wjsbeek, Rock and McCormick1972) observed changes in the phospholipid composition of uninfected cells from parasite donors. This suggested that when starting cultures parasite development might be improved with high dilutions of blood from uninfected donors.

Despite great care in following published methods, variability between laboratories of the biological components of the culture milieu impaired comparability. Poor parasite growth gave diminished multiplication. Efforts to improve matters by the addition of antioxidants in the form of vitamin C and vitamin E were unsuccessful. However, when monkeys were put on an ascorbic rich diet, their red cells supported better parasite development (McKee and Geiman, Reference McKee and Geiman1946; Butcher and Cohen, Reference Butcher and Cohen1971). Interestingly, on a relatively low vitamin C diet, cultured red cells were abnormal in shape (acanthocytic) resembling those of patients lacking vitamin E (abetalipoprotinaemia; Butcher, Reference Butcher1970). [As a temporary measure, whilst the dietary situation was being clarified, horse serum enabled some cultures to yield reasonable results (Butcher, Reference Butcher1970; Butcher, Reference Butcher1979)]. More recently, these vitamins have been shown to play an important role in protecting murine parasitized erythrocytes from oxidative stress (Stocker et al. Reference Stocker, Hunt, Weidermann and Clark1986). The nutritional status of the cell donors is thus important, as is the status of serum donors and when possible selection of screened, regular donors was highly desirable. As culture techniques improved, a primary aim of culturing knowlesi was to devise an entirely synthetic medium: that is one without serum. Whilst it was claimed that stearic acid could substitute for serum (Siddiqui et al. Reference Siddiqui, Schnell and Geiman1969), it was eventually concluded that good growth and multiplication could not be obtained in the absence of serum (see Bertagna et al. Reference Bertagna, Cohen, Geiman, Haworth, Konigk, Richards and Trigg1972). Modern substitutes for serum are however greatly improved, and in routine use.

By eliminating individual medium components, those that were essential to P. knowlesi in vitro became clear. These included p-aminobenzoic acid, isoleucine and methionine [at very low concentrations in monkey haemoglobin (Butcher, Reference Butcher1970; Siddiqui and Schnell, Reference Siddiqui and Schnell1972) biotin, pantothenate, pyrimidines, and a source of lipid, most effectively supplied by serum (Geiman et al. Reference Geiman, Siddiqui and Schnell1966; Siddiqui and Schnell, Reference Siddiqui and Schnell1972).

The requirements for in vitro studies on the erythrocytic stage of P. knowlesi and other Plasmodium spp. were outlined in a detailed review by Bertagna et al. (Reference Bertagna, Cohen, Geiman, Haworth, Konigk, Richards and Trigg1972). Advances in culture techniques from the 1970s to the mid-1980s were reviewed again in 1985 (Trigg, Reference Trigg1985), the salient difference between these two reviews being the development of continuous culture, initially of P. falciparum (Haynes et al. Reference Haynes, Diggs, Hines and Desjardins1976; Trager and Jensen, Reference Trager and Jensen1976) followed closely by P. knowlesi (Butcher, Reference Butcher1979; Wickham et al. Reference Wickham, Dennis and Mitchell1980). The successful maintenance of parasites in continuous culture was probably due to a number of factors including the use of modern proprietary media (Trigg, Reference Trigg1969) (especially RPMI1640), without antibiotics or with only neomycin or gentamycin, careful attention to cell concentrations, medium replacement, the use of HEPES buffer, low oxygen concentration and recognizing that different isolates, as observed with P falciparum, could be quite variable in their requirements (Butcher, Reference Butcher1982).

Plasmodium knowlesi continues to be of value as an experimental model in vitro, now adapted to human red cells (Moon et al. Reference Moon, Hall, Rangkuti, Ho, Almond, Mitchell, Pain, Holder and Blackman2013). Further developments included attempts to culture parasites in the absence of red cells (axenic culture, Nillni et al. Reference Nillni, Schmidt-Ullrich, Mikkelsen and Wallach1985) and improved methods for in vitro culture of exoerythrocytic stages (Millet et al. Reference Millet, Fisk, Collins, Broderson and Nguyen-Dinh1988) Latterly, culture has come to be seen as a means of parasite production (minimizing host exploitation), a means of studying precise moments in developmental cycles (such as egress from rupturing schizonts, and the specificity and characteristics of merozoite invasion of red cells), and finally as one of the enabling technologies for the organism's genetic manipulation. Aspects of in vitro work are covered in the following sections, and also in the companion paper by Bannister in this volume.

CHARACTERISTICS OF THE P. KNOWLESI–RHESUS MONKEY MODEL WHICH PROMOTED ITS USE AS AN EXPERIMENTAL TOOL

A number of characteristics of the knowlesi–rhesus combination were attractive to researchers over many years and were regarded as potentially more suitable for the research envisaged than avian or, later, rodent species. They are summarized here as background to many of the research reports which follow:

  1. (1) The quotidian asexual cycle of P. knowlesi is clearly more convenient than using species with a 48 or 72 h cycle.

  2. (2) In the rhesus monkey the parasites are highly synchronous: in the authors' experience (Cohen et al. Reference Cohen, Butcher and Crandall1969) the vast majority of parasites were early schizonts in the morning, they then multiplied over mid-day to give an almost pure preparation of ring forms in the afternoon. However, synchronicity was only retained for up to six to eight passages through monkeys (using infected blood); after that it became necessary to start with a new frozen stabilate. Multiplication rates were variable depending on the progress of the infection, but could be as high as 10-fold (Garnham, Reference Garnham1966).

  3. (3) As parasitaemias in the rhesus increased it became possible to separate schizonts from uninfected cells and rings by simple centrifugation (Brown and Brown, Reference Brown and Brown1965; Mitchell et al. Reference Mitchell, Butcher and Cohen1973). An upper layer of cells, clearly visible as a chocolate brown colour due to the haemozoin, consisted almost 100% of mature or developing schizonts, which were then used in a variety of experiments, including disruption by various means to provide a source of antigen.

  4. (4) Schizont preparations could be incubated in a specially designed cell sieve (Dennis et al. Reference Dennis, Mitchell, Butcher and Cohen1975) from which almost pure preparations of merozoites were obtained. The merozoites of P. knowlesi are larger than those of falciparum and could be counted readily on a haemocytometer and observed in the presence of red cells of different hosts (Butcher et al. Reference Butcher, Mitchell and Cohen1973) to determine those susceptible to invasion.

  5. (5) Although the rhesus monkey is highly susceptible to knowlesi, if carefully monitored the infection can be controlled with antimalarial drug treatment (Coggeshall and Kumm, Reference Coggeshall and Kumm1937; Collins et al. Reference Collins, Contacos, Skinner, Chin and Guinn1967; Butcher and Cohen, Reference Butcher and Cohen1972). Eventually, the monkeys become immune and able to withstand high challenge doses of parasites (up to 109); these animals were then a source of immune sera obtained by repeated bleeds without killing the monkey donor.

As noted above, as well as macaques and man, P. knowlesi will infect many old and new world primate species, including for instance the common marmoset (Callithrix jacchus), a particularly tractable laboratory host, but one in which relatively little work has been reported (Cruz and De mello, Reference Cruz and De Mello1947; Langhorne et al. Reference Langhorne, Butcher, Mitchell and Cohen1979).

PATHOLOGY OF P. KNOWLESI INFECTION

The extreme severity and almost uniform lethality of P. knowlesi in naive and untreated rhesus macaques led to investigation of the pathological processes involved. These seem to differ in detail from those found in lethal cases of P. falciparum, rendering the model less useful than would otherwise be the case, but features such as anaemia, and splenic and hepatic hyperplasia are in common (Menon, Reference Menon1939). The terminal events were characterized by Maegraith et al. as shock-like, with acute circulatory failure (Maegraith et al. Reference Maegraith, Devakul and Lighthead1959). Napier and Campbell (Reference Napier and Campbell1932) reported the tendency of the (then un-named) parasite to produce haemoglobinurea in macaques, and its fulminating nature in rhesus. Ground breaking work on mechanisms included in vivo microscopy, showing the ‘sludging’ of the circulation in the terminally ill monkey, with adhesion of blood cells to vascular endothelium (Knisely et al. Reference Knisely, Stratman-Thomas and Eliot1941). The mechanism was proposed as fibrin-like deposition on infected cells, initially being opsonic, but terminally associated with increased viscosity, reduction in capillary flow, and a tendency for leucocyte adherence to ‘sticky’ endothelium. Knowledge of adhesion molecules has modified the interpretation, but not detracted from the observations! The early work on pathology is reviewed by Clark and Tomlinson (Reference Clark, Tomlinson and Boyd1949).

Pathogenesis in human cases was studied in those being treated for syphilitic general paresis, and also in ‘volunteer’ prisoners in the US NIH Penitentiary facility, Atlanta. In an early series, of 12 infected patients and several rhesus monkeys in Scotland, patients were observed at two hourly intervals, showing pyrexia exceeding 104 °F (above 40 °C) and sometimes 20-fold multiplication over two schizogonic cycles, having become patent about a week after receiving, typically, 3 mL of infected rhesus blood (van Rooyen and Pile, Reference van Rooyen and Pile1935). Unfortunately the authors omit absolute parasitaemias. These workers showed monkey blood remained infective for up to 16 days if stored in an ice chest after defibrination, that patients' blood could infect a second and third case by passage, and that it remained infective to rhesus. Difficulty was found in infecting patients who had previously been treated with P. vivax. Their knowlesi patients' infections were controlled and terminated with atebrin (less effective in man than monkey) and quinine, and given supportive cardiac therapy with digitalis whilst suffering rigours. Ciuca et al. (Reference Ciuca, Ballif, Chelaresco, Lavrineko and Zotta1937) obtained knowlesi from Horton Hospital in the UK (where it had replaced vivax for malariotherapy) because of the difficulty of using such therapy in the then malaria-endemic Romania. In a first series of experiments they showed that prior exposure to P. vivax, P falciparum or P malariae all reduced the chance of successful infection with the simian parasite. When successfully induced, disease was sometimes severe with pyrexia above 40 °C, but extremely variable parasitaemia (unfortunately given as parasites per field) and sometimes profound anaemia. Interestingly gametocytes were rarely seen, but the line had been maintained solely by blood passage. Of 13 patients re-challenged with the same line after 1, 2, 3 or 4 months, nine remained negative. Of the four re-infected, only one could be infected a third time (2 weeks later); immunity in two was solid for 5 and 11 months, respectively. In the very large group of patients treated over many years by Ciuca et al. (Reference Ciuca, Chelarescu, Sofletea, Constantinescu, Teriteanu, Cortez, Balanovschi and Ilies1955), the virulence of parasites increased over multiple blood passages (some 170) and its use was subsequently abandoned. In a smaller series, Jolly et al. (Reference Jolly, Lavergne and Tanguy1937) had characterized the disease as mild and self-limiting in man.

Experimental sporozoite induced infection was carried out with the H strain in penitentiary volunteers by Chin et al. (Reference Chin, Contacos, Coatney and Kimball1965, Reference Chin, Contacos, Collins, Jeter and Alpert1968), and compared with blood passage as a route of infection. There was remarkable similarity, with peak parasitaemias often between 103 and 104 mm−3, around day 8 of patency, which in turn often lasted less than 20 days. Following mosquito bite, patency developed after 9–12 days, and was successfully achieved in man–mosquito–man and man–mosquito–monkey situations. Intriguingly, in the light of subsequent work by Miller's group (e.g. Mason et al. Reference Mason, Miller, Shiroishi, Dvorak and McGinniss1977), no difference was found in the susceptibility of white and Afro-Americans. With the notable exception of H, the lines used by the workers mentioned here are almost certainly no longer available, but it seems clear that differing isolates of P knowlesi vary in human pathogenicity.

As noted above, since it was possible to induce acquired immunity in the rhesus by sub-curative drug treatment in the face of its intense pathology, the nature and extent of this host's immune response became the focus of a great deal of research.

IMMUNITY TO P. KNOWLESI

The past few decades of the 19th century and the early years of the 20th century witnessed the beginnings of immunology. However, right at the start investigators tended to divide into two camps: those who believed in the overriding importance of cellular mechanisms in resistance to pathogens and those who regarded humoral immunity as the more important (Porter, Reference Porter1997). Inevitably these attitudes influenced ideas about immunity to malaria from the earliest studies, as recounted in an extremely detailed and comprehensive review of work published up to 1949 (Taliaferro, Reference Taliaferro and Boyd1949) The debate has continued right up to modern times, and results from experimentation on the knowlesi–rhesus model have been of major significance in this context. For the sake of clarity, the work on humoral immunity will be summarized first.

Antibody-mediated immunity

Many attempts were made with avian and occasionally human Plasmodium spp. to demonstrate a role for humoral immunity in malaria by the passive transfer of serum, following methods used for bacteria and bacterial toxins, but these were unsuccessful (summarized in Taliaferro, Reference Taliaferro and Boyd1949). The success of passive transfer of immunity by sera from immune rhesus, immunized by repeated infection and cure, with known numbers of P. knowlesi, provided the first secure evidence for the role of antibody in malaria (Coggeshall and Kumm, Reference Coggeshall and Kumm1937) though in some experiments quite large volumes of immune sera were required. Pre-incubation of parasites with immune sera, subsequently injected together into monkeys, resulted in best protection but attempts to induce immunity by different treatments of infected erythrocytes – formol or heat treatment and so forth – were unsuccessful (Coggeshall, Reference Coggeshall1943). Complement fixation was also demonstrated (Coggeshall and Eaton, Reference Coggeshall and Eaton1938) as well as the agglutination of schizont-infected red cells by immune sera.

Definitive evidence for antibody-mediated immunity in human malaria came from the success of Cohen and McGregor, in The Gambia, reducing parasitaemias of P. falciparum in young children given immune immunoglobulin from adults (Cohen et al. Reference Cohen, Mcgregor and Carrington1961). Timing of the reduction in parasitaemias suggested that the schizonts were the main target of antibody and encouraged the suggestion that a vaccine against malaria might be a possibility.

In an attempt to reproduce the Gambian results in a laboratory animal, it was hoped that by using minimal infective doses of P. knowlesi in rhesus monkeys simultaneously injected with immune IgG, the animals would be protected and this would provide a method of testing potential protective antigens. Unfortunately, such large doses of IgG were required to demonstrate any protective effect that this approach was clearly impractical (Butcher et al. Reference Butcher, Cohen and Garnham1970; Butcher and Cohen, Reference Butcher and Cohen1971). The failure of the knowlesi experiment in contrast to the success of the human experiments may have been due to a number of factors. First, P. falciparum parasites incubated in samples of the immune human immunoglobulin absorbed a 5-fold greater concentration of antibody than P. knowlesi incubated in immune rhesus IgG (Cohen and Butcher, Reference Cohen and Butcher1969). Further, immunity generated by infection and cure in rhesus monkeys caused no increase in immunoglobulin levels, in contrast to the higher production and turnover in humans (Cohen et al. Reference Cohen, Mcgregor and Carrington1961). Lastly, the infected Gambian children who received the immune IgG would have been experiencing greatly enhanced phagocytosis in their spleens, liver and bone marrow (see below) unlike the uninfected rhesus given antibody and parasites together. Interestingly, Mulligan et al. (Reference Mulligan, Sommerville and Swaminath1940) reported that immune sera were more effective against P. knowlesi if the monkeys were also infected with P. cynomolgi.

The in vivo approach was therefore abandoned in favour of in vitro culture using labelled amino acids to monitor parasite growth in order to assess the effect of antibody. Cultures of P. knowlesi from infected non-immune rhesus initiated with early schizonts supported development through one cycle, with multiplication rates of 3–6-fold, but in the presence of immune sera or IgG (to a lesser extent IgM) parasite multiplication was completely inhibited (Cohen and Butcher, Reference Cohen, Butcher and Crandall1969; Cohen et al. Reference Cohen, Butcher and Crandall1969) although there was no effect on parasite development within red cells. Microscopic observation of individual schizonts rupturing on a warm stage revealed agglutination of merozoites by immune sera, and their reduced ability to attach to red cells compared with parasites incubated in normal serum, visibly confirming that a major target of immune antibody was the merozoite (Butcher and Cohen, Reference Butcher and Cohen1970), a conclusion supported by other groups working with P. knowlesi (Miller et al. Reference Miller, Mason, Dvorak, McGinniss and Rothman1975) and subsequently in P. falciparum (Mitchell et al. Reference Mitchell, Butcher, Voller and Cohen1976).

The high degree of species and strain specificity of immunity between the simian malarias (Voller and Rossan, Reference Voller and Rossan1969a , Reference Voller and Rossan b ) and between human Plasmodium spp. (Taliaferro, Reference Taliaferro and Boyd1949; Cohen et al. Reference Cohen, Butcher and Mitchell1974) is consistent with the concept that once established, immunity is predominantly dependent on antibody.

Notwithstanding the inhibitory action of antibody outlined above, it was well known that parasites persist in the blood of hosts that are clearly immune [termed premunition; for summary and comparison of premunition and immunity see Garnham (Reference Garnham1966)]; a situation which puzzled researchers over many years. Brown and Brown (Reference Brown and Brown1965) took samples of infected blood from rhesus chronically infected with P. knowlesi, when there were sudden minor peaks in parasitaemia. These parasite samples were subsequently tested in an agglutination assay (SICA–schizont-infected cell agglutination assay) against sera from the same monkey which had been taken either before or after the parasites were isolated. They observed a pattern of changes in agglutination by sera before and after each peak which suggested that at each peak, a new surface antigen appeared on the schizont-infected red cell, termed antigenic variation. This demonstration of antigenic variation has proved pivotal in malaria research. Howard et al. (Reference Howard, Barnwell and Kao1983) showed that the antigen was a parasite product, and not modified host material, and by lactoperoxidase iodination were able to demonstrate molecular masses of the new proteins and the specificity of SICA antisera in immunoprecipitating them. This paved the way for understanding the variant gene family (SICAvar), and later the nature of PfEMP1 in P. falciparum. Despite the quite distant relationship between knowlesi and falciparum, there are significant homologies in the two families of variant antigens (Korir and Galinski, Reference Korir and Galinski2006).

By constantly changing an antigen on the surface of the infected erythrocyte, parasites could evade opsonizing antibody, thus at least partly explaining premunition. However, in a series of experiments in which monkeys were repeatedly infected and cured, despite the appearance of new SICA variants, the monkeys showed increased levels of protection, which correlated with rising levels of anti-merozoite antibody (Butcher and Cohen, Reference Butcher and Cohen1972). This result further encouraged the belief that a vaccine against malaria was possible and that protective antigens might be detected and characterized from the merozoite (see below). In an extraordinary twist, it was later shown that if the parasites were passaged in splenectomized monkeys, expression of SICA antigens was lost, and such parasites showed reduced virulence when used to infect intact rhesus monkeys (Barnwell et al. Reference Barnwell, Howard, Miller, Evered and Whelan1983).

Immunity in the natural host (M. fascicularis) has received almost no attention from researchers. Since most research on P. knowlesi used adult wild-caught monkeys, it was difficult to know to what degree immunity might vary between adults and juvenile animals, although it was well established that mature kra monkeys experienced no ill effects and kept parasite numbers at a low level, often barely detectable. A small study of knowlesi in young kra monkeys born in the UK and then infected with P. knowlesi parasites confirmed the view that the infection was easily controlled (maximum parasitaemia was 0·3%). Although inhibition of parasite growth in vitro by kra sera revealed a more rapid response than the rhesus, maximum levels of inhibition were much lower that observed with sera from immune rhesus (Butcher et al. Reference Butcher, Mitchell and Cohen2010). The immune mechanisms, which operate in the kra to keep parasites from overwhelming the host, remain a mystery. The same applies to the other simian malarias in their natural hosts (Butcher, Reference Butcher1992, Reference Butcher1996). Whatever these mechanisms might be, they require an intact spleen, but they could be overwhelmed by the injection of high parasite doses (Butcher, unpublished data).

Cell-mediated immunity

It was clear from numerous histological examinations of sections of organs of many malaria-infected hosts that phagocytic activity in the spleen, liver and bone marrow were greatly heightened (Taliaferro, Reference Taliaferro and Boyd1949). Non-parasitized and parasitized red cells as well as free pigment were taken up by macrophages and this was thought to be important in protection, though it was not quantifiable. However, in South American Cebus capucinus monkeys infected with P. brasilianum, in addition to the phagocytic activity, Taliaferro and colleagues observed damaged intracellular parasites and schizonts with few merozoites (Taliaferro and Taliaferro, Reference Taliaferro and Taliaferro1944). These were termed ‘crisis forms’ by analogy with the crisis in tuberculosis. In contrast, experienced malariologists such as Sir Ian McGregor FRS, who spent many years in Africa, never saw crisis forms in human infections, and did not know what they were (McGregor, personal communication). It was not surprising, therefore, that this aspect of immune responses remained largely ignored (see WHO, 1975) despite the Taliaferros' publications, until the 1970s.

The demonstration by M.W. Chase that immune responsiveness, characterized by delayed hypersensitivity reactions, could be transferred by lymphoid cells, as opposed to serum, provided the basis for investigations in cell-mediated immunity (see Daniel, Reference Daniel2010). In rodent malaria, Phillips (Reference Phillips1970) showed that specific immunity to P. berghei in rats could be transferred by lymphocytes. Clearly, experiments of this type could not be done in outbred monkeys, but other experiments to assess their immune status were undertaken.

Plasmodium knowlesi antigens injected intradermally into chronically-infected immune rhesus caused an immediate hypersensitivity response, confirming the importance of immune antibody, but delayed hypersensitivity reactions only occurred in animals immunized with schizonts in the presence of an adjuvant [Freund's complete adjuvant (FCA)], of which 50% survived challenge infections (Phillips et al. Reference Phillips, Wolstencroft, Brown, Brown and Dumonde1970). Attempts to demonstrate cytotoxic activity with immune spleen cells using 51Cr labelled parasitized erythrocytes gave a negative result (Brown et al. Reference Brown, Brown and Hills1970a , Reference Brown, Brown, Phillips, Trigg, Hills, Wolstencroft and Dumonde b ); Butcher et al. did similar experiments and obtained the same result (unpublished data and Langhorne et al. Reference Langhorne, Butcher, Mitchell and Cohen1979).

Cell-mediated immune cytotoxicity was demonstrated in knowlesi merozoite-immunized rhesus monkeys (see below) infected with P. cynomolgi challenged with high doses of P. knowlesi such that parasites were immediately patent (Butcher et al. Reference Butcher, Mitchell and Cohen1978). Damaged intracellular P. cynomolgi parasites were observed, but nevertheless the infection remained chronic. Interestingly, rhesus monkeys which had received an inadequate vaccine and were then challenged with P. knowlesi exhibited crisis forms but died later than usual, with very low parasitaemias, possibly reflecting an uncontrolled cell-mediated response (Mitchell, Reference Mitchell1975; also see below). Lastly, although crisis form parasites were detected in chronically infected kra monkeys, the infection was not cleared (Butcher et al. Reference Butcher, Mitchell and Cohen2010).

In parallel with the gradual accumulation of data on antibody mediated immunity and merozoite immunization in the 1970s, those who worked on rodent malaria were already familiar with crisis forms, which appeared as the infections peaked and parasitaemias declined, particularly Plasmodium chabaudi and Plasmodium vinckei. Progress on this aspect of responses to malarial infection has come from further work on rodent and human infections and is summarized by Clark (Reference Clark2009).

THE P. KNOWLESI MEROZOITE AS A SOURCE OF IMMUNOGEN

As emphasized above, by 1972, functional humoral immunity in rhesus monkeys which had been rendered resistant to P. knowlesi seemed to be largely directed against merozoites, and to limit the progress of disease by reducing or curtailing asexual multiplication at the point of red cell invasion. It was therefore logical to use purified merozoites as immunogen in an experimental vaccine. Despite the discrepant pathology, it was thought that such a demanding model for immunization might yield results applicable to Plasmodium falciparum in man.

Attempts to immunize rhesus had had a previous history: in general schizont infected cells had been used, rendered non-infectious after formol fixation, by Freund et al. – one of the first applications of his eponymous adjuvant – (Freund et al. Reference Freund, Thomson, Sommer, Walter and Pisani1948) and by Targett and Fulton (Reference Targett and Fulton1965), who also used immune serum-lysed cells; by Brown et al. (Reference Brown, Brown and Hills1970a ) after repeated freezing and thawing, and by French press disruption (Schenkel et al. Reference Schenkel, Simpson and Silverman1973). In general, FCA was used by these workers for primary immunization, followed by boosting with the incomplete adjuvant (FIA), and in summary 30–60% of immunized monkeys survived initial challenge infection. Where FIA was used in primary immunization, or where BCG or PolyAU adjuvants were used instead of FCA, protection was not seen (Brown et al. Reference Brown, Brown and Hills1970a , Reference Brown, Brown, Phillips, Trigg, Hills, Wolstencroft and Dumonde b ; Schenkel et al. Reference Schenkel, Simpson and Silverman1973). There is little basis for comparison of immunogen doses, but derivation from about 2 mL P.C.V., or approximately 1010 schizont infected cells, was representative. The SICA variant used in challenge was usually unknown (summarized in Mitchell et al. Reference Mitchell1975).

Immunization with preparations of naturally released merozoites (Mitchell et al. Reference Mitchell, Butcher and Cohen1973; Dennis et al. Reference Dennis, Mitchell, Butcher and Cohen1975) proved to be more successful than schizont-based vaccines. In a number of separate trials, the mean vaccine dose of 1·9 × 109 merozoites was contaminated with less than 0·1% host cells and was generally given at least twice in FCA. Of 21 monkeys thus treated, and challenged by inoculation of infected blood (104 parasites) or sporozoite suspension (2 × 103 sporozoites), or by infected mosquito bite, 20 survived. FIA and BCG were ineffective as adjuvants, and formol treatment of merozoites rendered them ineffective as immunogen (Mitchell, Reference Mitchell1977). Merozoites could be frozen or freeze-dried and retained protective immunogenicity (Mitchell et al. Reference Mitchell, Butcher, Langhorne and Cohen1977), but no attempt to replace FCA with a potentially clinically acceptable adjuvant was successful (Mitchell et al. Reference Mitchell, Richards, Voller, Dietrich and Dukor1979). Interestingly, the protection which followed merozoite vaccination was broader than would have been suggested by the titres of merozoite inhibitory antibody found in the vaccines, inhibitory antibody was induced when non-protective adjuvants were used, and splenectomy (which did not diminish circulating inhibitory antibody) rendered previously successfully protected monkeys susceptible to challenge (Butcher et al. Reference Butcher, Mitchell and Cohen1978).

Alternative routes to immunization with P. knowlesi

The understanding that transmission blockade could be a significant aspect of an effective vaccination strategy for malaria led to experiments to immunize rhesus monkeys with gamete-enriched and partly gamete-purified preparations of P. knowlesi. As well as developing antibodies which blocked fertilization in mosquitoes fed after challenge, the partly purified preparations induced considerable immunity to the asexual infection (Gwadz and Green, Reference Gwadz and Green1978). Again, FCA could not be functionally replaced.

The situation with sporozoite immunization differed: intramuscular immunization with FCA emulsified sporozoites was ineffective either for protection or for antibody induction. Both required intravenous inoculation of irradiated sporozoites. High levels of circulating antibody, when induced, correlated with protection against sporozoite challenge, but death from anaphylactic shock was suspected in one of four animals in one trial (Gwadz et al. Reference Gwadz, Cochrane, Nussenzweig and Nussenzweig1979). Whilst sporozoite immunization was not pursued to a great extent in P. knowlesi, an epoch-making advance for the field was made with this species: the genetic cloning of the first circumsporozoite protein in 1983 in Godson's laboratory (Ellis et al. Reference Ellis, Ozaki, Gwadz, Cochrane, Nussenzweig, Nussenzweig and Godson1983). This exemplified what was to become the familiar pattern of immunodominant multiple repeat epitopes in this category of surface protein.

EARLY ADVANCES IN THE ANALYSIS OF FUNCTION AND OF PROTECTIVE IMMUNOGENES OF P. KNOWLESI MEROZOITES

By the early 1980s, a nexus of interesting problems had emerged with regard to the asexual infection and immunity effective against it, together with the beginnings of the molecular technologies which were eventually to prove capable of commencing their resolution. These problems can be summarized as follows: how did the mechanism of red cell invasion relate to components of the merozoite, which could induce immune responses? The emergent technologies were gene cloning and monoclonal antibody techniques, but biological probes, inhibitors and labelling techniques all played important roles. Despite the advent in 1976 of reliable long-term cultivation and cyclical proliferation in vitro of P. falciparum, the advantages and existing understanding of P. knowlesi kept this species in intense experimental use.

The most readily available biological probes for invasion-related merozoite ligands were of course red cells. These could show the presence or absence of molecules required for recognition and invasion, and for P. knowlesi this had been approached by Butcher et al. (Reference Butcher, Mitchell and Cohen1973), using human, simian and pro-simian red cells in comparison with other mammalian red cells. In the same year, Miller et al. (Reference Miller, Dvorak, Shiroishi and Durocher1973) showed that receptors for P. knowlesi on human and macaque red cells differed by their sensitivity to enzymic removal. Band 3 protein, the red cell anion transporter, was suggested as a receptor. Miller extended this work, first by showing that Duffy blood group negative (FyFy) human r.b.c. were refractory to invasion (and by extension implicating this blood group in innate resistance to P. vivax seen in West Africa), and by showing that antibody to the Fya or Fyb determinants blocked invasion into cognate r.b.c. (Miller et al. Reference Miller, Mason, Dvorak, McGinniss and Rothman1975). It was also apparent that Duffy (much later characterized as the erythrocyte chemokine receptor (Horuk et al. Reference Horuk, Chitnis, Darbonne, Colby, Rybicki, Hadley and Miller1993)) was not uniquely necessary for knowlesi invasion, since the enzymic treatment of human Duffy negative cells rendered them susceptible without causing them to be Duffy positive (Mason et al. Reference Mason, Miller, Shiroishi, Dvorak and McGinniss1977). Despite this, it was clearly valuable to pursue identification of the merozoite binding partner(s) involved.

Differential Interference Contrast videomicroscopy (Dvorak et al. Reference Dvorak, Miller, Whitehouse and Shiroishi1975) and Electron Microscopy of invading merozoites (Bannister et al. Reference Bannister, Butcher, Dennis and Mitchell1975) had shown the steps in the invasion process, leading to a hypothesis for the invasion mechanisms, essentially derived from P. knowlesi, by Miller (Reference Mason, Miller, Shiroishi, Dvorak and McGinniss1977). This described merozoite attachment, the induction of red cell membrane upheaval, apical orientation of the merozoite, and its endocytosis followed by re-sealing of the parasitophorous vacuole membrane (PVM) so-formed. Hints of the addition of merozoite material to the developing PVM appeared later: freeze fracture studies suggested new proteins were inserted in the PVM during invasion (McLaren et al. Reference Mclaren, Bannister, Trigg and Butcher1977), but the addition of lipidic material was not proposed until some years afterwards (Bannister et al. Reference Bannister, Mitchell, Butcher and Dennis1986).

The initial invasion hypothesis needed modification in other respects, for instance in the light of specific chemical inhibitors of the process. Cytochalasin was shown to block invasion at the point of junction formation between the apical prominence of the merozoite and the red cell, so suggesting an actin dependent component (Miller et al. Reference Miller, Aikawa, Johnson and Shiroishi1979). Protease inhibitors (pepstatin, chymostatin, leupeptin, phosphoramidon and elastatinal) were shown variously to abort or partially inhibit the invasion process (Banyal et al. Reference Banyal, Misra, Gupta and Dutta1981). The release of merozoites from schizonts was unaffected and the use of pretreated r.b.c. was immaterial to invasion, suggesting that the invasion process itself depended in part on protease activity. However, these results were challenged, but also extended, by findings of Hadley et al. (Reference Hadley, Aikawa and Miller1983). Knowlesi invasion inhibition by chymostatin was confirmed (but not that due to pepstatin or leupeptin) and both N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK), and L-1-tosylamide-2-phenylethylchloromethyl ketone (TPCK) inhibited the process, but at different points: the latter two stopped attachment of merozoites to the red cell whereas chymostatin allowed events as far as junction formation. It was unclear if enzymic alteration of the target red cell, or modification of the merozoite's own surface proteins (or both) was implicated. The junction of the invading merozoite's apex with the red cell membrane had become a focus of special interest. This had been observed by Bannister et al. (Reference Bannister, Butcher, Dennis and Mitchell1975), but was named and described in detail by Aikawa et al. (Reference Aikawa, Miller, Johnson and Rabbege1978). Moreover, Miller et al. (Reference Miller, Aikawa, Johnson and Shiroishi1979) had demonstrated that knowlesi invasion into Duffy negative cells failed at the point of junction formation rather than initial attachment. It remained unclear if monoclonal antibody to rhesus r.b.c. Band 3 protein, which blocked invasion, did so at precisely the same point (Miller et al. Reference Miller, Hudson, Rener, Taylor, Hadley and Zilberstein1983). The value of this approach to merozoite function by red cell receptor studies is implicit in the continuing candidacy of the Duffy receptor protein in vaccination studies.

Monoclonal antibodies were key reagents with which to investigate origin, location and characteristics of merozoite molecules, which had been identified initially by screening the antibodies for inhibition of invasion. Two such merozoite molecules are exemplars: a 66 kD microneme protein, later to be called AMA-1, and a 140 kD merozoite surface protein (Deans et al. Reference Deans, Alderson, Thomas, Mitchell, Lennox and Cohen1982; Miller et al. Reference Miller, David, Hudson, Hadley, Richards and Aikawa1984). In both instances, antibody-affinity purified antigen was used in experimental vaccination of rhesus monkeys, but neither proved totally successful (David et al. Reference David, Hudson, Hadley, Klotz and Miller1985; Deans et al. Reference Deans, Knight, Jean, Waters, Cohen and Mitchell1988). AMA-1 nevertheless remains a viable candidate for immunization, partly because of its apparent constancy despite immune pressure (Deans et al. Reference Deans, Knight, Jean, Waters, Cohen and Mitchell1988). By contrast the 140 kD molecule varied when placed under the selection pressure imposed by the immunized monkeys (David et al. Reference David, Hudson, Hadley, Klotz and Miller1985). The occurrence of antigenic variation at the merozoite surface was not in itself surprising: it was the hallmark of schizont surfaces in recrudescing infection, and was strongly suggested by studies with merozoite-inhibitory antiserum, as reviewed above. Antigenic variation, thanks to P. knowlesi, must always be in the minds of those determined to vaccinate mankind against malaria.

Concluding remarks

This review is centred on the first 50 years of research on P. knowlesi (1932–1982) and while much was achieved, interesting questions still remain with regard to the interactions of host and parasite. Not least, why do these organisms not cause their simian natural hosts any apparent ill health, how do they continue to survive in the presence of immune responses, and what is different in the immune mechanisms in the rhesus that makes it so vulnerable compared with other closely related macaques? Clearly, and sadly, mankind is affected in a manner closer to that of M. mulatta than M. fascicularis.

We hope it is clear that early experimental and observational work on this malaria species was ground-breaking in important respects; we also hope that advantage to mankind still accrues from those studies.

ACKNOWLEDGEMENTS

The work of the authors described in this review was supported over many years mainly by the UK Medical Research Council, but also by the World Health Organisation Tropical Disease Research programme and The Royal Society.

ETHICAL AND REGULATORY GUIDELINES

Experimental research by the authors involving animals outlined here was licenced by the UK Home Office inspectorate under the guidance of the then Cruelty to Animals Act of 1876.

References

REFERENCES

Aberle, S. D. (1945). Primate Malaria. US National Research Council, Division of Medical Science, Washington, DC.Google Scholar
Ahmed, A. M., Pinheiro, M. M., Divis, P. C., Siner, A., Zainudin, R., Wong, I. T., Lu, C. W., Singh-Khaira, S. K., Millar, S. B., Lynch, S., Willmann, M., Singh, B., Krishna, S. and Cox-Singh, J. (2014). Disease progression in Plasmodium knowlesi malaria is linked to variation in invasion gene family members. PLoS Neglected Tropical Diseases 14, e3086.CrossRefGoogle Scholar
Aikawa, M., Miller, L. H., Johnson, J. and Rabbege, J. (1978). Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. Journal of Cell Biology 77, 7282.CrossRefGoogle ScholarPubMed
Anfinsen, C. B., Geiman, Q. M., McKee, R. W., Ormsbee, R. A. and Ball, E. G. (1946). Studies on malarial parasites. VIII. nutrition of Plasmodium knowlesi. Factors affecting the growth of Plasmodium knowlesi in vitro . Journal of Experimental Medicine 84, 607621.Google Scholar
Assefa, S., Lim, C., Preston, M. D., Duffy, C. W., Nair, M. B., Adroub, S. A., Kadir, K. A., Goldberg, J. M., Neafsey, D. E., Divis, P., Clark, T. G., Duraisingh, M. T., Conway, D. J., Pain, A. and Singh, B. (2015). Population genomic structure and adaptation in the zoonotic malaria parasite Plasmodium knowlesi . Proceedings of the National Academy of Sciences of the United States of America 112, 1302713032.CrossRefGoogle ScholarPubMed
Ball, E. G., McKee, R. W., Anfinsen, C. B., Cruz, W. O. and Geiman, Q. M. (1948). Studies on malarial parasites. IX. Chemical and metabolic changes during growth and multiplication in vivo and in vitro . Journal of Biological Chemistry 175, 547571.CrossRefGoogle Scholar
Bannister, L. H., Butcher, G. A., Dennis, E. D. and Mitchell, G. H. (1975). Structure and invasive behaviour of Plasmodium knowlesi merozoites in vitro . Parasitology 71, 483491.Google Scholar
Bannister, L. H., Mitchell, G. H., Butcher, G. A. and Dennis, E. D. (1986). Lamellar membranes associated with rhoptries in erythrocytic merozoites of Plasmodium knowlesi: a clue to the mechanism of invasion. Parasitology 92, 291303.CrossRefGoogle Scholar
Banyal, H. S., Misra, G. C., Gupta, C. M. and Dutta, G. P. (1981). Involvement of malarial proteases in the interaction between the parasite and host erythrocyte in Plasmodium knowlesi infections. Journal of Parasitology 67, 623626.Google Scholar
Barnwell, J. W., Howard, R. K. and Miller, L. H. (1983). Influence of the spleen on the expression of surface antigens on parasitized red cells. In Malaria and the Red Cell (ed. Evered, D. and Whelan, J.), pp. 117136. CIBA Foundation Symposium 94. Pitman, London.Google Scholar
Bass, C. C. and Johns, F. M. (1912). The cultivation of malarial plasmodia (Plasmodium vivax and Plasmodium falciparum) in vitro . Journal of Experimental Medicine 16, 567579.Google Scholar
Bertagna, P., Cohen, S., Geiman, Q. M., Haworth, J., Konigk, E., Richards, W. H. G. and Trigg, P. I. (1972). Cultivation techniques for the erythrocytic stages of malaria parasites. Bulletin of the World Health Organisation 47, 357373.Google Scholar
Brown, I. N. and Brown, K. N. (1965). Immunity to malaria: antigenic variation in chronic infections of P. knowlesi . Nature 208, 12861288.Google Scholar
Brown, K. N., Brown, I. N. and Hills, L. A. (1970 a). Immunity to malaria: I protection against Plasmodium knowlesi shown by monkeys sensitised by drug-suppressed infections or by dead parasites in Freund's adjuvant. Experimental Parasitology 28, 304317.CrossRefGoogle ScholarPubMed
Brown, K. N., Brown, I. N., Phillips, R. S., Trigg, P. L., Hills, L. A., Wolstencroft, R. A. and Dumonde, D. C. (1970 b). Immunity to malaria: studies with Plasmodium knowlesi . Transactions of the Royal Society of Tropical Medicine and Hygiene 64, 35.Google ScholarPubMed
Butcher, G. A. (1970). Experimental studies on immunity to Plasmodium knowlesi . Ph.D. thesis. University of London, London.Google Scholar
Butcher, G. A. (1979). Factors affecting the in vitro culture of Plasmodium falciparum and Plasmodium knowlesi . Bulletin of the World Health Organisation 57 (Suppl. 1) 1726.Google Scholar
Butcher, G. A. (1982). The behaviour of different strains of Plasmodium falciparum in suspension and static culture. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 407409.Google Scholar
Butcher, G. A. (1992). Immunity to simian malaria in the natural hosts–problems for investigation. Southeast Asian Journal of Tropical Medicine and Public Health 23, 177183.Google Scholar
Butcher, G. A. (1996). Models for malaria: nature knows best. Parasitology Today 12, 378382.Google Scholar
Butcher, G. A. and Cohen, S. (1970). Schizogony of Plasmodium knowlesi in the presence of normal and immune sera. Transactions of the Royal Society of Tropical Medicine and Hygiene 64, 470 (Film).CrossRefGoogle ScholarPubMed
Butcher, G. A. and Cohen, S. (1971). Short term culture of Plasmodium knowlesi . Parasitology 62, 309320.CrossRefGoogle ScholarPubMed
Butcher, G. A. and Cohen, S. (1972). Antigenic variation and protective immunity in Plasmodium knowlesi malaria. Immunology 23, 503521.Google Scholar
Butcher, G. A., Cohen, S. and Garnham, P. C. C. (1970). Passive immunity in Plasmodium knowlesi malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 64, 850856.Google Scholar
Butcher, G. A., Mitchell, G. H. and Cohen, S. (1973). Mechanisms of host specificity in malarial infection. Nature 244, 4042.Google Scholar
Butcher, G. A., Mitchell, G. H. and Cohen, S. (1978). Antibody mediated mechanisms of immunity to malaria induced by vaccination with Plasmodium knowlesi merozoites. Immunology 34, 7786.Google Scholar
Butcher, G. A., Mitchell, G. H. and Cohen, S. (2010). Plasmodium knowlesi infections in a small number of non-immune natural hosts (Macaca fascicularis) and in rhesus monkeys (Macaca mulatta). Transactions of the Royal Society of Tropical Medicine and Hygiene 104, 7577.Google Scholar
Cheong, W. H., Warren, M. W., Omar, A. H. and Mahadevan, S. (1965). Anopheles balabacensis balabacensis identified as vector of simian malaria in Malaysia. Science 150, 1314.CrossRefGoogle ScholarPubMed
Chin, W., Contacos, P. G., Coatney, G. R. and Kimball, H. R. (1965). A naturally acquired quotidian type malaria in man transferable to monkeys. Science 149, 865.Google Scholar
Chin, W., Contacos, P. G., Collins, W. E., Jeter, M. H. and Alpert, E. (1968). Experimental mosquito transmission of Plasmodium knowlesi to man and monkey. American Journal of Tropical Medicine and Hygiene 17, 355358.CrossRefGoogle Scholar
Ciuca, M., Ballif, L., Chelaresco, M., Lavrineko, M. and Zotta, E. (1937). Contributions a l'etude de l'action pathogene de Pl knowlesi pour l'homme (Considerations sur l'immunite naturalle et l'immunite acquise contre cette espece de parasite). Bulletin de la Societe de Pathologie Exotique 30, 305315.Google Scholar
Ciuca, M., Chelarescu, M., Sofletea, A., Constantinescu, P.,Teriteanu, E.,Cortez, P., Balanovschi, G. and Ilies, M. (1955). Contribution experimentale a l’ etude de l'immunite dans le paludisme Editions Acad. Rep. Pop. Roumaine pp108 (not seen; cited in Coatneyi et al. 1971).Google Scholar
Clark, H. C. and Tomlinson, W. J. (1949). Pathological anatomy of malaria. In Malariology, Vol. 2 (ed. Boyd, M. F.), pp. 874903. W B Saunders, Philadelphia.Google Scholar
Clark, I. A. (2009). Along a TNF-paved road from dead parasites in red cells to cerebral malaria and beyond. Parasitology 136, 14571468.CrossRefGoogle ScholarPubMed
Coatney, G. R., Collins, W., Warren, M. and Contacos, P. G. (1971). The Primate Malarias. US Department of Health, Education and Welfare, Bethesda, MD, USA.Google Scholar
Cohen, S. and Butcher, G. A. (1969). Comments on immunisation. Military Medicine (Special Issue) 134, 11911197.Google Scholar
Cohen, S., Mcgregor, I. A. and Carrington, S. C. (1961). Gamma globulin and acquired immunity to human malaria. Nature 192, 733737.Google Scholar
Cohen, S., Butcher, G. A. and Crandall, R. B. (1969). Action of malarial antibody in vitro . Nature 223, 368371.Google Scholar
Cohen, S., Butcher, G. A. and Mitchell, G. H. (1974). Mechanisms of immunity to malaria. Bulletin of the World Health Organisation 50, 251257.Google Scholar
Coggeshall, L. T. (1943). Immunity to malaria. Medicine 22, 87102.CrossRefGoogle Scholar
Coggeshall, L. T. and Eaton, M. (1938). Complement fixation reaction in monkey malaria. Journal of Experimental Medicine 68, 29.Google Scholar
Coggeshall, L. T. and Kumm, H. W. (1937). Demonstration of passive immunity in experimental monkey malaria. Journal of Experimental Medicine 66, 177190.CrossRefGoogle ScholarPubMed
Collins, W. E. (2012). Plasmodium knowlesi: a malaria parasite of monkeys and humans. Annual Review of Entomology 57, 107121.Google Scholar
Collins, W. E., Contacos, P. G., Skinner, J. C., Chin, W. and Guinn, E. (1967). Fluorescent-antibody studies on simian malaria I Development of antibodies to Plasmodium knowlesi . American Journal of Tropical Medicine and Hygiene 16, 16.Google Scholar
Cox-Singh, J. and Singh, B. (2008). Knowlesi malaria: newly emergent and of public health importance. Trends in Parasitology 24, 406410.Google Scholar
Cox-Singh, J., Davis, T. M. E., Lee, K.-S., Shamsul, S. S., Matusop, A., Rahman, H. A., Conway, D. J. and Singh, B. (2008). Plasmodium knowlesi in humans is widely distributed and potentially life-threatening. Clinical Infectious Diseases 46, 165171.Google Scholar
Cruz, W. O. and De Mello, R. P. (1947). Infeccao do macaco sul americano ‘sagui’ (Callithrix jacchus) como Plasmodium knowlesi . Memorias do Instituto Oswaldo Cruz 45, 119121.CrossRefGoogle Scholar
Daniel, T. M. (2010). Merrill Wallace Chase and cellular immunology (Founders of our knowledge). International Journal of Tuberculosis and Lung Disease 14, 397398.Google Scholar
David, P. H., Hudson, D. E., Hadley, T. J., Klotz, F. W. and Miller, L. H. (1985). Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein. Journal of Immunology 134, 41464152.Google Scholar
Deans, J. A., Alderson, T., Thomas, A. W., Mitchell, G. H., Lennox, E. S. and Cohen, S. (1982). Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi . Clinical and Experimental Immunology 49, 297309.Google ScholarPubMed
Deans, J. A., Knight, A. M., Jean, W. C., Waters, A. P., Cohen, S. and Mitchell, G. H. (1988). Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kilodalton merozoite antigen. Parasite Immunology 10, 535552.CrossRefGoogle Scholar
Dennis, E. D., Mitchell, G. H., Butcher, G. A. and Cohen, S. (1975). In vitro isolation of Plasmodium knowlesi merozoites using polycarbonate sieves. Parasitology 71, 475481.Google Scholar
De Zeeuw, R. A., Wjsbeek, J., Rock, R. C. and McCormick, G. J. (1972). Composition of phospholipids in Plasmodium knowlesi membranes and in host rhesus erythrocyte membranes. Proceedings of the Helminthological in Society of Washington 39 (Special Issue), 412418.Google Scholar
Dunn, M. J. (1969). Alterations of red blood cell metabolism in simian-malaria: evidence for abnormalities of non-parasitised cells. Military Medicine (Special Issue) 134, 11001105.Google Scholar
Dvorak, J. A., Miller, L. H., Whitehouse, W. C. and Shiroishi, T. (1975). Invasion of erythrocytes by malaria merozoites. Science 187, 748750.Google Scholar
Edeson, J. F. B. and Davey, D. G. (1953). Isolation of a virulent strain of Plasmodium knowlesi Sinton and Mulligan 1932. Transactions of the Royal Society of Tropical Medicine and Hygiene 47, 259260.Google Scholar
Ellis, J., Ozaki, L. S., Gwadz, R. W., Cochrane, A. H., Nussenzweig, V., Nussenzweig, R. S. and Godson, G. N. (1983). Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi . Nature 302, 536538.Google Scholar
Franchini, G. (1927). Su di un plasmodio pigmentato di una scimmmia. Arch Ital Sci Med Colon Parassit 8, 187190 (not seen; cited in Garnham 1966).Google Scholar
Freund, J., Thomson, K. J., Sommer, H. E., Walter, A. W. and Pisani, T. M. (1948). Immunisation of monkeys against malaria by means of killed parasites with adjuvants. American Journal of Tropical Medicine 28, 122.Google Scholar
Garnham, P. C. C. (1966). Malaria Parasites and Other Haemosporidia. Blackwell Scientific Publications, Oxford.Google Scholar
Geiman, Q. M., Anfinsen, C. B., McKee, R. W., Ormsbee, R. A. and Ball, E. G. (1946). Studies on malarial parasites : vii. Methods and techniques for cultivation. Journal of Experimental Medicine 84, 583606. Google Scholar
Geiman, Q. M., Siddiqui, W. A. and Schnell, J. V. (1966). In vitro studies on erythrocytic stages of plasmodia. Medium improvement and results with seven species of malarial parasites. Military Medicine (Supplement) 131, 10151025.Google Scholar
Gwadz, R. W. and Green, I. (1978). Malaria immunization in rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi . Journal of Experimental Medicine 148, 13111323.Google Scholar
Gwadz, R. W., Cochrane, A. H., Nussenzweig, V. and Nussenzweig, R. S. (1979). Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bulletin of the World Health Organisation 57 (Suppl. 1), 165173.Google Scholar
Hadley, T., Aikawa, M. and Miller, L. H. (1983). Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors. Experimental Parasitology 55, 306311.Google Scholar
Haynes, J. D., Diggs, C. L., Hines, F. A. and Desjardins, R. E. (1976). Culture of human malaria parasites Plasmodium falciparum . Nature 263, 767769.Google Scholar
Horuk, R., Chitnis, C. E., Darbonne, W. C., Colby, T. J., Rybicki, A., Hadley, T. J. and Miller, L. H. (1993). A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science. 261, 11821184.CrossRefGoogle ScholarPubMed
Howard, R. J., Barnwell, J. W. and Kao, V. (1983). Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. Proceedings of the National Academy of Sciences of the United States of America 80, 41294133.Google Scholar
Hsieh, H. C. (1960). Malaria parasites of the Taiwan monkey. Formosan Science 14, 477487 (not seen; cited in Coatneyi et al. 1971).Google Scholar
Jiram, A. I., Vythilingam, I., NoorAzian, Y. M., Yusof, Y. M., Azahari, A. H. and Fong, M. Y. (2012). Entomologic investigation of Plasmodium knowlesi vectors in Kuala Lipis, Pahang, Malaysia. Malaria Journal 11, 213.Google Scholar
Jolly, A. M. D., Lavergne, X. and Tanguy, Y. (1937). Etude experimentale du Plasmodium knowlesi chez le singe et chez l'homme. Annales de l'Institut Pasteur 58, 297325 (not seen; cited in Coatney et al 1971).Google Scholar
Knisely, M. H., Stratman-Thomas, W. K. and Eliot, T. S. (1941). Observation on circulating blood in the small vessels of internal organs in living Macacus rhesus infected with malarial parasites. Anatomical Record 79, 90.Google Scholar
Knowles, P. and Das Gupta, B. M. (1932). A study of monkey malaria and its experimental transmission to man. Indian Medical Gazette LXVII, 301320.Google Scholar
Korir, C. C. and Galinski, M. R. (2006). Proteomic studies of Plasmodium knowlesi SICA variant antigens demonstrate their relationship with P. falciparum EMP1. Infection Genetics and Evolution 6, 7579.Google Scholar
Lambrecht, F. L., Dunn, F. L. and Eyles, D. E. (1961). Isolation of Plasmodium knowlesi from Philippine macaques. Nature 191, 11171118.Google Scholar
Langhorne, J., Butcher, G. A., Mitchell, G. H. and Cohen, S. (1979). Preliminary investigations on the role of the spleen in immunity to Plasmodium knowlesi malaria. In Role of the Spleen in the Immunology of Parasitic Diseases. Tropical Disease Research Series 1, pp. 205225. UNDP/WORLD BANK/WHO, Schwabe, Basel.Google Scholar
Maegraith, B. G., Devakul, K. and Lighthead, C. S. (1959). The terminal stages of Plasmodium knowlesi infection in Macaca mulatta . Annals of Tropical Medicine and Parasitology 53, 369379.Google Scholar
Mason, S. J., Miller, L. H., Shiroishi, T., Dvorak, J. A. and McGinniss, M. H. (1977). The Duffy blood group determinants: their role in the susceptibility of human and animal erythrocytes to Plasmodium knowlesi malaria. British Journal of Haematology 36, 327335.Google Scholar
McKee, R. W. and Geiman, Q. M. (1946). Studies on malarial parasites V. Effects of ascorbic acid on malaria (Plasmodium knowlesi) in monkeys. Proceedings of the Society for Experimental Biology and Medicine 63, 313315.Google Scholar
Mclaren, D. J., Bannister, L. H., Trigg, P. I. and Butcher, G. A. (1977). A freeze-fracture study on the parasite-erythrocyte interrelationship in Plasmodium knowlesi infections. Bulletin of the World health Organisation 55, 199203.Google Scholar
Menon, T. B. (1939). The visceral lesions in simian malaria with special reference to the splenic reaction. Transactions of the Royal Society of Tropical Medicine and Hygiene 32, 481495.CrossRefGoogle Scholar
Miller, L. H. (1977). Hypothesis on the mechanism of erythrocyte invasion by malaria merozoites. Bulletin of the World Health Organisation 55, 157–62Google Scholar
Miller, L. H., Dvorak, J. A., Shiroishi, T. and Durocher, J. R. (1973). Influence of erythrocyte membrane components on malaria merozoite invasion. Journal of Experimental Medicine 138, 15971601.Google Scholar
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H. and Rothman, I. K. (1975). Erythrocyte receptors for (Plasmodium knowlesi) malaria: duffy blood group determinants. Science 189, 561563.Google Scholar
Miller, L. H., Powers, K. G. and Shiroishi, T. (1977). Plasmodium knowlesi: functional immunity and antimerozoite antibodies in rhesus monkeys after repeated infection. Experimental Parasitology 41, 105111.Google Scholar
Miller, L. H., Aikawa, M., Johnson, J. G. and Shiroishi, T. (1979). Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation. Journal of Experimental Medicine 149, 172184.Google Scholar
Miller, L. H., Hudson, D., Rener, J., Taylor, D., Hadley, T. J. and Zilberstein, D. (1983). A monoclonal antibody to rhesus erythrocyte band 3 inhibits invasion by malaria (Plasmodium knowlesi) merozoites. Journal of Clinical Investigation 134, 41464152.Google Scholar
Miller, L. H., David, P. H., Hudson, D. E., Hadley, T. J., Richards, R. L. and Aikawa, M. (1984). Monoclonal antibodies to a 140,000-m.w. protein on Plasmodium knowlesi merozoites inhibit their invasion of rhesus erythrocytes. Journal of Immunology 132, 438442.Google Scholar
Millet, P., Fisk, T. L., Collins, W. E., Broderson, J. R. and Nguyen-Dinh, P. (1988). Cultivation of exoerythrocytic stages of Plasmodium cynomolgi, P. knowlesi, P. coatneyi and P. inui in Macaca mulatta hepatocytes. American Journal of Tropical Medicine and Hygiene 39, 529534.Google Scholar
Mitchell, G. H. (1975). Experimental studies on acquired malarial immunity. Ph.D. thesis. University of London, London.Google Scholar
Mitchell, G. H. (1977). A review of merozoite vaccination against Plasmodium knowlesi malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 71, 281282.Google Scholar
Mitchell, G. H., Butcher, G. A. and Cohen, S. (1973). Isolation of blood-stage merozoites from Plasmodium knowlesi malaria. International Journal of Parasitology 3, 443445.Google Scholar
Mitchell, G. H., Butcher, G. A., Voller, A. and Cohen, S. (1976). The effect of human immune IgG on the in vitro development of Plasmodium falciparum . Parasitology 72, 149162.Google Scholar
Mitchell, G. H., Butcher, G. A., Langhorne, J. and Cohen, S. (1977). A freeze dried merozoite vaccine effective against Plasmodium knowlesi malaria. Clinical and Experimental Immunology 28, 276279.Google Scholar
Mitchell, G. H., Richards, W. H. G., Voller, A., Dietrich, F. M. and Dukor, P. (1979). Nor-MDP, saponin, corynebacteria, and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques. Bulletin of the world Health Organisation 57 (Suppl. 1), 189197.Google Scholar
Mitchell, G. H., Butcher, G. A., Cohen, S. (1975). Merozoite vaccination against Plasmodium knowlesi malaria. Immunology 29, 397407.Google Scholar
Moon, R. W., Hall, J., Rangkuti, F., Ho, Y. S., Almond, N., Mitchell, G. H., Pain, A., Holder, A. A., and Blackman, M. J. (2013). Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proceedings of the National Academy of Scince of the United States of America 110, 531536.Google Scholar
Mulligan, H. W. and Sinton, J. A. (1933). Superinfection with various strains of monkey malaria. Record of the Malaria Survey, India 3, 529568.Google Scholar
Mulligan, H. W., Sommerville, T. and Swaminath, C. S. (1940). Cellular and humoral agencies in defence against malaria. Journal of the Malaria Institute of India 3, 563579.Google Scholar
Mun, Y. F., Ahmed, M. A., Wong, S. S., Yee, L. L. and Sitam, F. (2015). Genetic diversity and natural selection of the Plasmodium knowlesi circumsporozoite protein nonrepeat regions. PLoS ONE 10, e0137734.Google Scholar
Napier, L. E. and Campbell, H. G. M. (1932). Observations on a plasmodium infection which causes haemoglobinuria in certain species of monkey. Indian Medical Gazette 67, 151160.Google Scholar
Nillni, E. A., Schmidt-Ullrich, R., Mikkelsen, R. B. and Wallach, D. F. (1985). Extracellular development of Plasmodium knowlesi erythrocytic stages in an artificial intracellular medium. Molecular and Biochemical Parasitology 17, 219237.Google Scholar
Pain, A., Böhme, U., Berry, A. E., Mungall, K., Finn, R. D., Jackson, A. P., Mourier, T., Mistry, J., Pasini, E. M., Aslett, M. A., Balasubrammaniam, S., Borgwardt, K., Brooks, K., Carret, C., Carver, T. J., Cherevach, I., Chillingworth, T., Clark, T. G., Galinski, M. R., Hall, N., Harper, D., Harris, D., Hauser, H., Ivens, A., Janssen, C. S., Keane, T., Larke, N., Lapp, S., Marti, M., Moule, S. et al. (2008). The genome of the simian and human malaria parasite Plasmodium knowlesi . Nature 455, 799803.Google Scholar
Phillips, R. S. (1970). Plasmodium berghei: passive transfer of immunity by antisera and cells. Experimental Parasitology 27, 479495.CrossRefGoogle ScholarPubMed
Phillips, R. S., Wolstencroft, R. A., Brown, I. N., Brown, I. N. and Dumonde, D. C. (1970). Immunity to malaria III Posssible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's Adjuvant-sensitised monkeys. Experimental Parasitology 28, 339355.CrossRefGoogle Scholar
Pinheiro, M. M., Ahmed, M. A., Millar, S. B., Sanderson, T., Otto, T. D., Lu, W. C., Krishna, S., Rayner, J. C. and Cox-Singh, J. (2015). Plasmodium knowlesi genome sequences from clinical isolates reveal extensive genomic dimorphism. PLoS ONE 10, e0121303.Google Scholar
Porter, R. (1997). The Greatest Benefit to Mankind. Fontana Press, London, pp. 445448.Google Scholar
Russell, P. F. (1955). Man's Mastery of Malaria. OUP, London, p. 1.Google Scholar
Schenkel, R. H., Simpson, G. L. and Silverman, P. H. (1973). Vaccination of rhesus monkeys (Macaca mulatta) against Plasmodium knowlesi by the use of non-viable antigen. Bulletin of the World Health Organisation 48, 597604.Google Scholar
Sharma, S., Svec, P., Mitchell, G. H. and Godson, G. N. (1985). Diversity of circumsporozoite antigen genes from two strains of the malarial parasite Plasmodium knowlesi . Science 229, 779782.Google Scholar
Siddiqui, W. A. and Schnell, J. V. (1972). In vitro and in vivo studies with Plasmodium falciparum and Plasmodium knowlesi . Proceedings of the Helminthological in Society of Washington 39 (Special- Issue), 204210.Google Scholar
Siddiqui, W. A., Schnell, J. V. and Geiman, Q. M. (1969). Nutritional requirements for in vitro cultivation of a simian malarial parasite, Plasmodium knowlesi . Military Medicine 134 (Special Issue), 929938.Google Scholar
Sinton, J. A. and Mulligan, H. W. (1932). A critical review of the literature relating to the identification of the malarial parasites recorded from monkeys of the families Cercopithecidae and Colobidae. Records of the Malaria Survey of India 3, 357380.Google Scholar
Stocker, R., Hunt, N. H., Weidermann, M. J. and Clark, I. A. (1986). Protection of vitamin E from oxidation by increased by ascorbic acid content within Plasmodium vinckei-infected erythrocytes. Biochemica Biophysica Acta 876, 294299.Google Scholar
Taliaferro, W. H. (1949). Immunity to the malarial infections. In Malariology (ed. Boyd, M. F.), pp. 935965. Saunders, Philadelphia.Google Scholar
Taliaferro, W. H. and Taliaferro, L. G. (1944). The effect of immunity on the asexual reproduction of Plasmodium brasilianum . Journal of Infectious Diseases 75, 132.Google Scholar
Tan, C. H., Vythilingam, I., Matusop, A., Chan, S. T. and Singh, B. (2008). Bionomics of Anopheles latens in Kapit, Sarawak, Malaysian Borneo in relation to the transmission of zoonotic simian malaria parasite Plasmodium knowlesi . Malaria Journal 7, 52.Google Scholar
Targett, G. A. T. and Fulton, J. D. (1965). Immunisation of rhesus monkeys against Plasmodium knowlesi . Experimental Parasitology 17, 180193.Google Scholar
Trager, W. and Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science 193, 673675.CrossRefGoogle ScholarPubMed
Trigg, P. I. (1969). The use of proprietary tissue-culture media for the cultivation in vitro of the erythrocytic stages of Plasmodium knowlesi . Parasitology 59, 925935.Google Scholar
Trigg, P. I. (1985). Recent advances in malaria parasite cultivation and their application to studies on host-parasite relationships: a review. Bulletin of the World Health Organisation 63, 387398.Google Scholar
Trigg, P. I. and Shakespeare, P. G. (1976). The effect of incubation in vitro on the susceptibility of monkey erythrocytes to invasion by Plasmodium knowlesi . Parasitology 73, 149160.Google Scholar
van Rooyen, C. E. and Pile, G. R. (1935). Observations on infection by Plasmodium knowlesi (ape malaria) in the treatment of general paralysis of the insane. British Medical Journal 2, 662666.CrossRefGoogle ScholarPubMed
Voller, A. and Rossan, R. N. (1969 a). Immunological studies with simian malarias. II Heterologous immunity in the “cynomolgi” group. Transactions of the Royal Society of Tropical Medicine and Hygiene 63, 5763.Google Scholar
Voller, A. and Rossan, R. N. (1969 b). Immunological studies on simian malaria.III Immunity to challenge and antigenic variation in P. knowlesi . Transactions of the Royal Society of Tropical Medicine and Hygiene 63, 507523.Google Scholar
Wharton, R. H. and Eyles, D. E. (1961). Anopheles hackeri, a vector of Plasmodium knowlesi in Malaya. Science 134, 279280.Google Scholar
Wheatley, B. P. (1980). Malaria as a possible selective factor in the speciation of macaques. Journal of Mammology 61, 304307.Google Scholar
Wickham, J. M., Dennis, E. D. and Mitchell, G. H. (1980). Long term cultivation of a simian malaria parasite (Plasmodium knowlesi) in a semi-automated apparatus. Transactions of the Royal Society of Tropical Medicine and Hygiene 74, 789792.Google Scholar
Wong, M. L., Chua, T. H., Leong, C. S., Khaw, L. T., Fornace, K., Wan-Sulaiman, W. Y., William, T., Drakeley, C., Ferguson, H. M. and Vythilingam, I. (2015). Seasonal and spatial dynamics of the primary vector of Plasmodium knowlesi within a major transmission focus in Sabah, Malaysia. PLoS Neglected Tropical Diseases 9, e0004135.Google Scholar
World Health Organisation (1975). Developments in Malaria Immunology. Technical Report Series, No 579, WHO, Geneva.Google Scholar